BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25263811)

  • 1. Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients?
    Massaro KS; Macedo R; de Castro BS; Dulley F; Oliveira MS; Yasuda MA; Levin AS; Costa SF
    Infection; 2014 Dec; 42(6):1023-32. PubMed ID: 25263811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
    Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of serum procalcitonin and C-reactive protein for infections after allogeneic hematopoietic stem cell transplantation versus nontransplant setting.
    Mori Y; Miyawaki K; Kato K; Takenaka K; Iwasaki H; Harada N; Miyamoto T; Akashi K; Teshima T
    Intern Med; 2011; 50(19):2149-55. PubMed ID: 21963733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation.
    Michel CS; Teschner D; Wagner EM; Theobald M; Radsak MP
    Ann Hematol; 2017 Dec; 96(12):2095-2101. PubMed ID: 28920169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients.
    Pihusch M; Pihusch R; Fraunberger P; Pihusch V; Andreesen R; Kolb HJ; Holler E
    Eur J Haematol; 2006 Feb; 76(2):93-101. PubMed ID: 16405429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [C reactive protein and procalcitonin levels for the diagnosis of invasive bacterial infections in allogenic hematopoietic stem cell transplantation recipients].
    Schmidt N; Palma J; King A; Santolaya ME
    Rev Med Chil; 2007 Aug; 135(8):982-9. PubMed ID: 17989854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of risk factors related to the prognosis in patients with late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation].
    Chen Y; Wang Y; Jiang ZH; Xu LP; Zhang XH; Chen H; Chen YY; Wang FR; Wang JZ; Han W; Zhang YY; Han TT; Tang FF; Mo XD; Sun YQ; Yan CH; Liu KY; Huan XJ
    Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):804-809. PubMed ID: 29136708
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation.
    Harada K; Sekiya N; Konishi T; Nagata A; Yamada Y; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Yasuda S; Sasaki S; Yoshioka K; Watakabe-Inamoto K; Igarashi A; Najima Y; Hagino T; Muto H; Kobayashi T; Doki N; Kakihana K; Sakamaki H; Ohashi K
    BMC Infect Dis; 2017 Sep; 17(1):638. PubMed ID: 28938875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
    Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
    Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
    Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V
    Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation.
    Ortega M; Rovira M; Filella X; Martínez JA; Almela M; Puig J; Carreras E; Mensa J
    Bone Marrow Transplant; 2006 Mar; 37(5):499-502. PubMed ID: 16415895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients.
    Cabanillas Stanchi KM; Queudeville M; Malaval C; Feucht J; Schlegel P; Dobratz M; Seitz C; Müller I; Lang P; Handgretinger R; Döring M
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2779-2791. PubMed ID: 31446489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study.
    Işlak Mutcalı S; Saltoğlu N; Balkan İİ; Özaras R; Yemişen M; Tabak F; Mert A; Öztürk R; Öngören Ş; Başlar Z; Aydın Y; Ferhanoğlu B; Soysal T
    Turk J Haematol; 2016 Dec; 33(4):304-310. PubMed ID: 26377840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
    Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
    Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia.
    Aimoto M; Koh H; Katayama T; Okamura H; Yoshimura T; Koh S; Nanno S; Nishimoto M; Hirose A; Nakamae M; Nakane T; Nakamae H; Kakeya H; Hino M
    Infection; 2014 Dec; 42(6):971-9. PubMed ID: 25038889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study.
    Brodska H; Drabek T; Malickova K; Kazda A; Vitek A; Zima T; Markova M
    Crit Care; 2009; 13(2):R37. PubMed ID: 19291300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.
    Halder R; Seth T; Chaturvedi PK; Mishra P; Mahapatra M; Pati HP; Tyagi S; Saxena R
    Blood Cells Mol Dis; 2020 Sep; 84():102445. PubMed ID: 32480243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations.
    Youssef A; Hafez H; Madney Y; Elanany M; Hassanain O; Lehmann LE; El Haddad A
    Pediatr Transplant; 2020 Feb; 24(1):e13610. PubMed ID: 31682054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.
    García de Guadiana-Romualdo L; Español-Morales I; Cerezuela-Fuentes P; Consuegra-Sánchez L; Hernando-Holgado A; Esteban-Torrella P; Jiménez-Santos E; Viqueira-González M; de Béjar-Almira Á; Albaladejo-Otón MD
    Support Care Cancer; 2015 Jul; 23(7):2175-82. PubMed ID: 25564222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.